Zobrazeno 1 - 10
of 264
pro vyhledávání: '"rotateq™"'
Autor:
Gerardo Luna-Casas, Patricia Juliao, Roberto Carreño-Manjarrez, Andrés Castañeda-Prado, Maria Yolanda Cervantes-Apolinar, Ricardo Navarro-Rodriguez, Gilberto Sánchez-González, Ricardo Cortés-Alcalá, Rodrigo DeAntonio
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 6, Pp 1251-1259 (2019)
Worldwide, rotavirus infection has been a leading cause of severe diarrhea morbidity and mortality. Two rotavirus vaccines have been used in the National Immunization Program (NIP) in Mexico; two-dose Rotarix from 2006 to 2011 and three-dose RotaTeq
Externí odkaz:
https://doaj.org/article/719d4ae5c11a48ac8b4f5e4989ac2056
Autor:
A.D. Steele, J.C. Victor, M.E. Carey, J.E. Tate, D.E. Atherly, C. Pecenka, Z. Diaz, U.D. Parashar, C.D. Kirkwood
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 6, Pp 1215-1227 (2019)
Rotavirus vaccines have been introduced into over 95 countries globally and demonstrate substantial impact in reducing diarrheal mortality and diarrheal hospitalizations in young children. The vaccines are also considered by WHO as “very cost effec
Externí odkaz:
https://doaj.org/article/8d38b539456844a1ac1a3327baca33a4
Autor:
Roczo-Farkas, Susie, Kirkwood, Carl D., Cowley, Daniel, Barnes, Graeme L., Bishop, Ruth F., Bogdanovic-Sakran, Nada, Boniface, Karen, Donato, Celeste M., Bines, Julie E.
Publikováno v:
The Journal of Infectious Diseases, 2018 Aug . 218(4), 546-554.
Externí odkaz:
https://www.jstor.org/stable/26495593
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 11, Pp 1037-1051 (2018)
Introduction: Latin American countries were among the first to adopt rotavirus vaccines into national immunization programs; we reviewed one decade of their experience with rotavirus vaccination. Areas covered: We systematically reviewed manuscripts
Externí odkaz:
https://doaj.org/article/6b35247572df4fc0ab73faa16fa497c5
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 7, Pp 593-606 (2018)
Introduction: Prior to 2006, nearly every U.S. child was infected with rotavirus by 5 years of age, and rotavirus was the leading cause of severe childhood gastroenteritis. In February 2006 and June 2008, the Advisory Committee on Immunization Practi
Externí odkaz:
https://doaj.org/article/ec138f4e8be643a193d1ff3daa566fc2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Khitam Muhsen, Daniel Cohen
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 7, Pp 1722-1727 (2017)
We present an overview of the impact of universal rotavirus immunization with the pentavalent vaccine, RotaTeq, which was introduced in Israel in 2010. The vaccine is given free of charge at age 2, 4 and 6 months, with an 80% coverage that was shortl
Externí odkaz:
https://doaj.org/article/76c43a3f42e649288d63c74bcd57e1e6
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 73-78 (2017)
Rotavirus infection is the second after pneumococcal cause in the incidence of diseases and mortality in children under 5 years. That has defined the who’s recommendation for the introduction of vaccination against rotavirus infection in the vaccin
Externí odkaz:
https://doaj.org/article/35231f8d0b1c4137aa56d5fc28bf6012
Publikováno v:
Vaccines, Vol 9, Iss 4, p 406 (2021)
This study evaluated the long-term impact of rotavirus vaccination on prevalence, seasonality, and genotype distribution in Gwangju, Korea for 13 seasons. Rotavirus was identified using ELISA and then sequenced for G and P genotypes by Reverse Transc
Externí odkaz:
https://doaj.org/article/40f1da0a71d34c4ab74be98f4dd11c18